Unknown

Dataset Information

0

The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial.

ABSTRACT:

SUBMITTER: Matsuoka T 

PROVIDER: S-EPMC11985196 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial.

Matsuoka Tasuku T   Yamamoto Yurie Y   Yashiro Masakazu M  

Translational cancer research 20250320 3

Similar Datasets

Unknown Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer.
| S-EPMC8741424 | biostudies-literature
Unknown Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer.
| S-EPMC10735273 | biostudies-literature
Unknown HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers.
| S-EPMC11786065 | biostudies-literature
Unknown Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer.
| S-EPMC10937240 | biostudies-literature
Unknown HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
| S-EPMC9996199 | biostudies-literature
Unknown HER2DX ERBB2 score in advanced HER2-positive gastric cancer treated with trastuzumab and chemotherapy.
| S-EPMC12451336 | biostudies-literature
Unknown Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.
| S-EPMC10777675 | biostudies-literature
Unknown HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from the PHERGain Phase II Trial.
| S-EPMC11393543 | biostudies-literature
Unknown Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer.
| S-EPMC12869160 | biostudies-literature
Unknown A narrative review of advances in treatment and survival prognosis of HER2-positive malignant lung cancers.
| S-EPMC8264687 | biostudies-literature